학술논문
Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial
Document Type
Article
Author
Bellmunt, Joaquim ; Hussain, Maha; Gschwend, Jürgen E; Albers, Peter; Oudard, Stephane; Castellano, Daniel; Daneshmand, Siamak; Nishiyama, Hiroyuki; Majchrowicz, Martin; Degaonkar, Viraj; Shi, Yi; Mariathasan, Sanjeev; Grivas, Petros; Drakaki, Alexandra; O'Donnell, Peter H; Rosenberg, Jonathan E; Geynisman, Daniel M; Petrylak, Daniel P; Hoffman-Censits, Jean; Bedke, Jens; Kalebasty, Arash Rezazadeh; Zakharia, Yousef; van der Heijden, Michiel S; Sternberg, Cora N; Davarpanah, Nicole N; Powles, Thomas
Source
In The Lancet Oncology April 2021 22(4):525-537
Subject
Language
ISSN
1470-2045